SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 144 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,975,419 | +0.3% | 85,442 | +13.8% | 0.00% | 0.0% |
| Q2 2023 | $1,968,676 | +119.5% | 75,083 | +115.5% | 0.00% | 0.0% |
| Q1 2023 | $896,910 | +3.3% | 34,845 | +0.6% | 0.00% | 0.0% |
| Q4 2022 | $868,287 | -8.0% | 34,621 | +1.7% | 0.00% | 0.0% |
| Q3 2022 | $943,781 | +9.4% | 34,036 | -0.8% | 0.00% | 0.0% |
| Q2 2022 | $862,493 | -46.8% | 34,326 | +23.2% | 0.00% | 0.0% |
| Q1 2022 | $1,621,933 | +71.1% | 27,867 | +82.8% | 0.00% | 0.0% |
| Q4 2021 | $948,000 | -2.2% | 15,248 | -0.2% | 0.00% | 0.0% |
| Q3 2021 | $969,000 | -30.0% | 15,276 | -9.1% | 0.00% | 0.0% |
| Q2 2021 | $1,385,000 | +35.8% | 16,808 | +21.2% | 0.00% | 0.0% |
| Q1 2021 | $1,020,000 | -3.9% | 13,867 | -5.2% | 0.00% | 0.0% |
| Q4 2020 | $1,061,000 | +72.2% | 14,635 | +13.3% | 0.00% | 0.0% |
| Q3 2020 | $616,000 | +11.8% | 12,919 | -1.5% | 0.00% | 0.0% |
| Q2 2020 | $551,000 | +175.5% | 13,119 | +77.1% | 0.00% | – |
| Q1 2020 | $200,000 | – | 7,407 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |